GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (TSE:4540) » Definitions » Cyclically Adjusted Price-to-FCF

Tsumura (TSE:4540) Cyclically Adjusted Price-to-FCF : 69.12 (As of May. 17, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Tsumura Cyclically Adjusted Price-to-FCF?

As of today (2024-05-17), Tsumura's current share price is 円3947.00. Tsumura's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was 円57.10. Tsumura's Cyclically Adjusted Price-to-FCF for today is 69.12.

The historical rank and industry rank for Tsumura's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:4540' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.27   Med: 50.27   Max: 76.92
Current: 71.3

During the past years, Tsumura's highest Cyclically Adjusted Price-to-FCF was 76.92. The lowest was 36.27. And the median was 50.27.

TSE:4540's Cyclically Adjusted Price-to-FCF is ranked worse than
74.31% of 327 companies
in the Drug Manufacturers industry
Industry Median: 33.44 vs TSE:4540: 71.30

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Tsumura's adjusted free cash flow per share data for the three months ended in Mar. 2024 was 円-6.638. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円57.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tsumura Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tsumura's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Cyclically Adjusted Price-to-FCF Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.82 68.09 43.80 36.77 66.61

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.77 41.95 43.56 47.25 66.61

Competitive Comparison of Tsumura's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsumura's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tsumura's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tsumura's Cyclically Adjusted Price-to-FCF falls into.



Tsumura Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tsumura's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=3947.00/57.1
=69.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsumura's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tsumura's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-6.638/107.2000*107.2000
=-6.638

Current CPI (Mar. 2024) = 107.2000.

Tsumura Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 13.910 98.000 15.216
201409 -49.400 98.500 -53.763
201412 -13.896 97.900 -15.216
201503 -16.930 97.900 -18.538
201506 99.923 98.400 108.859
201509 -21.311 98.500 -23.193
201512 -7.515 98.100 -8.212
201603 68.359 97.900 74.853
201606 19.979 98.100 21.832
201609 102.531 98.000 112.156
201612 -3.644 98.400 -3.970
201703 63.648 98.100 69.552
201706 108.066 98.500 117.611
201709 -6.630 98.800 -7.194
201712 -14.044 99.400 -15.146
201803 57.169 99.200 61.779
201806 53.677 99.200 58.006
201809 -76.748 99.900 -82.356
201812 -45.698 99.700 -49.136
201903 23.111 99.700 24.850
201906 36.230 99.800 38.916
201909 -6.195 100.100 -6.634
201912 -7.609 100.500 -8.116
202003 77.704 100.300 83.050
202006 63.510 99.900 68.151
202009 21.344 99.900 22.904
202012 -6.993 99.300 -7.549
202103 9.528 99.900 10.224
202106 5.019 99.500 5.407
202109 84.187 100.100 90.158
202112 29.905 100.100 32.026
202203 21.096 101.100 22.369
202206 11.607 101.800 12.223
202209 13.437 103.100 13.971
202212 -63.328 104.100 -65.214
202303 61.169 104.400 62.810
202306 -62.924 105.200 -64.120
202309 -48.330 106.200 -48.785
202312 -71.899 106.800 -72.168
202403 -6.638 107.200 -6.638

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tsumura  (TSE:4540) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tsumura Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tsumura's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (TSE:4540) Business Description

Industry
Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (TSE:4540) Headlines

No Headlines